Free Trial

Moody Aldrich Partners LLC Sells 46,796 Shares of Cactus, Inc. (NYSE:WHD)

Cactus logo with Energy background

Moody Aldrich Partners LLC lowered its position in shares of Cactus, Inc. (NYSE:WHD - Free Report) by 38.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 73,758 shares of the company's stock after selling 46,796 shares during the quarter. Moody Aldrich Partners LLC owned approximately 0.09% of Cactus worth $3,380,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Cactus by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 7,680,731 shares of the company's stock worth $448,247,000 after purchasing an additional 147,395 shares in the last quarter. Geode Capital Management LLC increased its position in Cactus by 2.6% in the 4th quarter. Geode Capital Management LLC now owns 1,804,107 shares of the company's stock valued at $105,308,000 after acquiring an additional 45,821 shares in the last quarter. Capital International Investors increased its position in Cactus by 14.8% in the 4th quarter. Capital International Investors now owns 1,686,858 shares of the company's stock valued at $98,445,000 after acquiring an additional 218,004 shares in the last quarter. First Trust Advisors LP increased its position in Cactus by 34.6% in the 4th quarter. First Trust Advisors LP now owns 1,556,565 shares of the company's stock valued at $90,841,000 after acquiring an additional 400,452 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Cactus by 3.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,238,420 shares of the company's stock valued at $72,271,000 after acquiring an additional 43,237 shares in the last quarter. Institutional investors and hedge funds own 85.11% of the company's stock.

Cactus Price Performance

NYSE WHD traded down $1.35 during midday trading on Monday, hitting $43.92. The company had a trading volume of 414,811 shares, compared to its average volume of 702,712. The company has a market capitalization of $3.51 billion, a PE ratio of 15.63 and a beta of 1.48. The company has a current ratio of 4.85, a quick ratio of 3.47 and a debt-to-equity ratio of 0.01. The firm has a 50-day moving average price of $43.26 and a 200-day moving average price of $48.90. Cactus, Inc. has a twelve month low of $33.80 and a twelve month high of $70.01.

Cactus (NYSE:WHD - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.03. The firm had revenue of $280.32 million during the quarter, compared to analysts' expectations of $272.22 million. Cactus had a return on equity of 18.99% and a net margin of 16.78%. The company's quarterly revenue was up 2.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.75 EPS. As a group, analysts anticipate that Cactus, Inc. will post 3.08 earnings per share for the current fiscal year.

Cactus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Monday, June 2nd were paid a $0.13 dividend. The ex-dividend date was Monday, June 2nd. This represents a $0.52 annualized dividend and a dividend yield of 1.18%. Cactus's payout ratio is 18.51%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Stifel Nicolaus lowered their price objective on shares of Cactus from $61.00 to $57.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Barclays reduced their price objective on shares of Cactus from $54.00 to $53.00 and set an "overweight" rating on the stock in a research note on Friday, June 20th. Finally, JPMorgan Chase & Co. cut their price target on shares of Cactus from $52.00 to $50.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Cactus currently has an average rating of "Hold" and an average target price of $52.33.

Check Out Our Latest Research Report on Cactus

About Cactus

(Free Report)

Cactus, Inc, together with its subsidiaries, designs, manufactures, sells, and leases pressure control and spoolable pipes in the United States, Australia, Canada, the Middle East, and internationally. It operates through two segments, Pressure Control and Spoolable Technologies. The Pressure Control segment designs, manufactures, sells, and rents a range of wellhead and pressure control equipment under the Cactus Wellhead brand name through service centers.

See Also

Institutional Ownership by Quarter for Cactus (NYSE:WHD)

Should You Invest $1,000 in Cactus Right Now?

Before you consider Cactus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cactus wasn't on the list.

While Cactus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines